Effective MR Molecular Imaging of Triple Negative Breast Cancer With an EDB-Fibronectin-Specific Contrast Agent at Reduced Doses

MR molecular imaging (MRMI) of abundant oncogenic biomarkers in tumor microenvironment has the potential to provide precision cancer imaging in high resolution. Extradomain-B fibronectin (EDB-FN) is an oncogenic extracellular matrix protein, highly expressed in aggressive triple negative breast canc...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nadia R. Ayat, Amita Vaidya, Grace A. Yeung, Megan N. Buford, Ryan C. Hall, Peter L. Qiao, Xin Yu, Zheng-Rong Lu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2019-12-01
Col·lecció:	Frontiers in Oncology
Matèries:	EDB-fibronectin GBCAs targeted MRI contrast agent breast cancer tumor microenvironment
Accés en línia:	https://www.frontiersin.org/article/10.3389/fonc.2019.01351/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!